Related Experiment Video

Updated: Aug 10, 2026

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
08:28

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

Toxic and metabolic causes of seizures

D O'Brien1

  • 1Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia 65211, USA.

Clinical Techniques in Small Animal Practice
|October 17, 1998
PubMed

Insights

Reactive seizures, often caused by toxins or metabolic issues, occur when the brain cortex responds to external problems. Correcting the underlying cause offers a chance to eliminate these seizures.

Area of Science:

  • Neurology
  • Toxicology
  • Metabolic Disorders

Background:

  • Seizures are a common cerebral cortex response to various insults.
  • Reactive seizures stem from extracranial diseases, toxins, or metabolic disturbances.
  • These seizures disrupt the nervous system's excitation-inhibition balance or energy metabolism.

Purpose of the Study:

  • To explore the mechanisms by which toxins and metabolic diseases induce seizures.
  • To highlight the link between extracranial conditions and seizure activity.
  • To emphasize the potential for seizure resolution through underlying cause correction.

Main Methods:

  • Review of literature on toxic and metabolic etiologies of seizures.
  • Analysis of neurochemical pathways affected by toxins and metabolic changes.
  • Examination of drug interactions and pharmacokinetic alterations in metabolic disease.

Main Results:

  • Toxins and drugs can induce seizures by altering neuronal excitability and energy metabolism.
  • Metabolic diseases contribute to seizures via metabolic disruption, osmolality changes, and endogenous toxin production.
  • Metabolic conditions can affect the efficacy of antiepileptic and pro-convulsant drugs.

Conclusions:

  • Reactive seizures are a significant indicator of underlying toxic or metabolic conditions.
  • Understanding these mechanisms is crucial for diagnosis and treatment.
  • Early detection and correction of the root cause can potentially resolve reactive seizures and epilepsy.

More Related Videos

Pentylenetetrazole-Induced Kindling Mouse Model07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy06:58

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy

Published on: July 12, 2021

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Seizures ll: Types01:19

Seizures ll: Types

Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...